Reviva Pharmaceuticals (RVPH) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.4
-0.33
-0.25
-0.18

Details

Expected EPS
-0.22
Actual EPS
-0.38
Surprise EPS
-0.16
Surprise Percent
+72.73%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.38 per share for Q4 2022.

0 Comments

Share your thoughts